Last Updated: 04/06/07
About the Associate Director
Sheila Taube, Ph.D., has served as Associate Director of the DCTD Cancer Diagnosis Program (CDP) since 1997. Under Dr. Taube’s leadership, CDP has launched the Program for the Assessment of Clinical Cancer Tests (PACCT), which is designed to ensure efficient and effective translation of new knowledge and technology related to cancer diagnosis into clinical practice.
More…
Overview
The Cancer Diagnosis Program (CDP) strives to improve the diagnosis and assessment of cancer by effectively moving new scientific advances into clinical practice. The program stimulates, coordinates, and funds resources and research on diagnostics and improved technologies to better characterize cancers in order to develop information that can aid cancer patients and their physicians in clinical decision-making.
CDP supports research at medical centers, hospitals, businesses, and universities throughout the United States, Canada, and other countries.
CDP supports research at medical centers, hospitals, businesses, and universities throughout the United States, Canada, and other countries.
CDP is divided into three branches:
- Diagnostic Biomarkers and Technology Branch
- Resources Development Branch
- Diagnostics Evaluation Branch
CDP, often in cooperation with other programs of the National Cancer Institute (NCI), offers a range of initiatives that encourage and support research in cancer diagnostics and related development of technology and specimen resources. CDP administered approximately 400 funded grants in 2005.
